---
title: "Apellis Pharma (APLS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/APLS.US/norm.md"
symbol: "APLS.US"
name: "Apellis Pharma"
parent: "https://longbridge.com/en/quote/APLS.US.md"
datetime: "2026-05-20T13:58:40.753Z"
locales:
  - [en](https://longbridge.com/en/quote/APLS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/APLS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/APLS.US/norm.md)
---

# Apellis Pharma (APLS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.1461 | -0.4886 | 1.67 | -0.3345 | -0.7400 |
| ROE | 19.01% | -61.14% | 309.56% | -105.21% | -187.85% |
| Revenue | 268.30M | 199.91M | 458.58M | 178.49M | 166.80M |
| Net income | 18.66M | -58.95M | 215.72M | -42.15M | -92.22M |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.08B | 1.08B | 1.06B | 821.39M | 807.28M |
| Leverage | 2.61 | 2.90 | 2.64 | 5.25 | 4.92 |
| BVPS | 3.24 | 2.92 | 3.17 | 1.24 | 1.31 |
| Turnover | 1.17 | 1.02 | 1.04 | 0.8745 | 0.9466 |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -60.97M | -14.18M | 108.47M | 4.45M | -53.41M |
| Investing CF | - | -108000.00 | -148000.00 | -49000.00 | -8000.00 |
| Financing CF | 64000.00 | 1.26M | 793000.00 | 6.56M | 274000.00 |
| Free CF | -72.87M | -3.19M | 23.93M | 13.15M | -24.16M |